Literature DB >> 15824996

A molecular epidemiological analysis of 2 Staphylococcus aureus clonal types colonizing and infecting patients with AIDS.

Rachel J Gordon1, Bianca Quagliarello, Christian Cespedes, Marilyn Chung, Herminia de Lencastre, Peter Vavagiakis, Maureen Miller, Barbara Zeller, Franklin D Lowy.   

Abstract

BACKGROUND: Persons with acquired immune deficiency syndrome (AIDS) who use drugs appear to be at increased risk for colonization and infection with Staphylococcus aureus. Little is known about the nature of and risk factors responsible for this association. This study is among the first to prospectively follow carriage and infection in this uniquely high-risk population.
METHODS: We prospectively followed the cases of 75 patients with AIDS in a residential drug treatment facility and screened for S. aureus nasal colonization and infection.
RESULTS: Thirty-seven baseline cultures (49%) were positive for S. aureus, and 81% of subjects were colonized at least once during the study. Thirteen subjects experienced 17 infections. Pulsed-field gel electrophoresis and sequence-based typing methods revealed that 244 (92%) of the isolates belonged to either clonal type A or B. Clonal type A was methicillin-susceptible. Clonal type B consisted of 3 main subtypes (B1, B2, and B3), all with the same allelic profile (ST8) and staphylococcal protein A gene (spa) type (7). Of note, subtype B1 was methicillin-susceptible (ST8 and spa type 7), lacking mecA, whereas the other B clones were methicillin-resistant. Both clones were resistant to trimethoprim-sulfamethoxazole. Clonal type B isolates were relatively resistant, suggesting prior exposure to the health care setting.
CONCLUSIONS: This study demonstrates a sustained high rate of S. aureus carriage and infection. It demonstrates the capacity of unique methicillin-resistant S. aureus clones with an established linkage to earlier outbreaks of methicillin-resistant S. aureus, as well as to human immunodeficiency virus--infected subjects, to persist in this residential setting. It also illustrates the apparent genetic instability or transmissibility of the staphylococcal chromosomal cassette mec type IV element.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824996     DOI: 10.1086/428612

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Unusually high prevalence of nosocomial Panton-Valentine leukocidin-positive Staphylococcus aureus isolates in Cape Verde Islands.

Authors:  M Aires-de-Sousa; T Conceição; H de Lencastre
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

2.  Molecular characterization of methicillin-resistant Staphylococcus aureus clinical isolates obtained from the Rikers Island Jail System from 2009 to 2013.

Authors:  Joshua Tanner; Ying Lin; John Kornblum; Carolyn T A Herzig; Rachel Bystritsky; Anne-Catrin Uhlemann; Franklin D Lowy
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

3.  The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals.

Authors:  Rachel J Gordon; Nancy Chez; Haomiao Jia; Barbara Zeller; Magda Sobieszczyk; Caitlin Brennan; Katherine B Hisert; Mei-Ho Lee; Peter Vavagiakis; Franklin D Lowy
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

4.  Origins and evolution of methicillin-resistant Staphylococcus aureus clonal lineages.

Authors:  A R Gomes; H Westh; H de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 5.  Community-associated methicillin-resistant Staphylococcus aureus case studies.

Authors:  Madeleine G Sowash; Anne-Catrin Uhlemann
Journal:  Methods Mol Biol       Date:  2014

6.  Real-time PCR to distinguish livestock-associated (ST398) from non-livestock-associated (methicillin-resistant) Staphylococcus aureus.

Authors:  M L J G M van Meurs; J J A Schellekens; A J de Neeling; B Duim; P M Schneeberger; M H A Hermans
Journal:  Infection       Date:  2012-09-01       Impact factor: 3.553

7.  Methicillin-resistant Staphylococcus aureus in HIV-infected patients.

Authors:  Alicia I Hidron; Russell Kempker; Abeer Moanna; David Rimland
Journal:  Infect Drug Resist       Date:  2010-08-06       Impact factor: 4.003

8.  Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients.

Authors:  G N Delorenze; M A Horberg; M J Silverberg; A Tsai; C P Quesenberry; R Baxter
Journal:  Epidemiol Infect       Date:  2013-02-18       Impact factor: 4.434

9.  Staphylococcus epidermidis Protection Against Staphylococcus aureus Colonization in People Living With Human Immunodeficiency Virus in an Inner-City Outpatient Population: A Cross-Sectional Study.

Authors:  Sean B Sullivan; Suneel Kamath; Thomas H McConville; Brett T Gray; Franklin D Lowy; Peter G Gordon; Anne-Catrin Uhlemann
Journal:  Open Forum Infect Dis       Date:  2016-12-20       Impact factor: 3.835

10.  Molecular characterisation of methicillin-resistant Staphylococcus aureus (MRSA) isolated at a large referral hospital in Zambia.

Authors:  Mulemba Tillika Samutela; Annie Kalonda; James Mwansa; Chileshe Lukwesa-Musyani; John Mwaba; Enoch Mulowa Mumbula; Darlington Mwenya; Edgar Simulundu; Geoffrey Kwenda
Journal:  Pan Afr Med J       Date:  2017-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.